Share

'Betrayal': 6 reactions to FDA's approval of generic abortion drug

By Samantha Kamman, Christian Post Reporter

4. Karoline Leavitt 

White House press secretary Karoline Leavitt speaks during the daily press briefing in the Brady Press Briefing Room at the White House on Sept. 22, 2025, in Washington, D.C. Leavitt discussed a range of topics during the briefing, including Charlie Kirk, energy, gas prices and inflation.
White House press secretary Karoline Leavitt speaks during the daily press briefing in the Brady Press Briefing Room at the White House on Sept. 22, 2025, in Washington, D.C. Leavitt discussed a range of topics during the briefing, including Charlie Kirk, energy, gas prices and inflation. | Andrew Harnik/Getty Images

White House press secretary Karoline Leavitt told reporters this week that the FDA was following the law in approving the generic form of mifepristone, according to The Hill.

“It’s not an endorsement of this drug by any means. They are just simply following the law,” Leavitt said. “By law, the secretary of the Department of Health and Human Services must approve a generic drug application if the application demonstrates the drug is the ‘same’ as the brand-name drug.”

Samantha Kamman is a reporter for The Christian Post. She can be reached at: samantha.kamman@christianpost.com. Follow her on Twitter: @Samantha_Kamman

You’ve readarticles in the last 30 days.

Was this article helpful?

Help keep The Christian Post free for everyone.

Our work is made possible by the generosity of supporters like you. Your contributions empower us to continue breaking stories that matter, providing clarity from a biblical worldview, and standing for truth in an era of competing narratives.

By making a recurring donation or a one-time donation of any amount, you’re helping to keep CP’s articles free and accessible for everyone.

We’re sorry to hear that.

Hope you’ll give us another try and check out some other articles. Return to homepage.

Most Popular